Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits

Abstract

To search for new sequence variants that confer risk of cutaneous basal cell carcinoma (BCC), we conducted a genome-wide SNP association study of 930 Icelanders with BCC and 33,117 controls. After analyzing 304,083 SNPs, we observed signals from loci at 1p36 and 1q42, and replicated these associations in additional sample sets from Iceland and Eastern Europe. Overall, the most significant signals were from rs7538876 on 1p36 (OR = 1.28, P = 4.4 × 10−12) and rs801114 on 1q42 (OR = 1.28, P = 5.9 × 10−12). The 1p36 locus contains the candidate genes PADI4, PADI6, RCC2 and ARHGEF10L, and the gene nearest to the 1q42 locus is the ras-homolog RHOU. Neither locus was associated with fair pigmentation traits that are known risk factors for BCC, and no risk was observed for melanoma. Approximately 1.6% of individuals of European ancestry are homozygous for both variants, and their estimated risk of BCC is 2.68 times that of noncarriers.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Association of chromosome 1p36 region with BCC.
Figure 2: Allele rs7538876[A] is associated with increased expression of RCC2 in adipose tissue–derived RNA.
Figure 3: Multigenic risk model for BCC based on susceptibility variants at 1p36, 1q42, ASIP, TYR and MC1R loci.

Similar content being viewed by others

References

  1. Lear, J.T., Hoban, P., Strange, R.C. & Fryer, A.A. Basal cell carcinoma: from host response and polymorphic variants to tumour suppressor genes. Clin. Exp. Dermatol. 30, 49–55 (2005).

    Article  CAS  Google Scholar 

  2. Devlin, B. & Roeder, K. Genomic control for association studies. Biometrics 55, 997–1004 (1999).

    Article  CAS  Google Scholar 

  3. Kutyavin, I.V. et al. A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res. 34, e128 (2006).

    Article  Google Scholar 

  4. Scherer, D. et al. MC1R variants associated susceptibility to basal cell carcinoma of skin: interaction with host factors and XRCC3 polymorphism. Int. J. Cancer 122, 1787–1793 (2007).

    Article  Google Scholar 

  5. Roewert-Huber, J., Lange-Asschenfeldt, B., Stockfleth, E. & Kerl, H. Epidemiology and aetiology of basal cell carcinoma. Br. J. Dermatol. 157 (Suppl. 2), 47–51 (2007).

    Article  CAS  Google Scholar 

  6. Xu, L.Y. & Koo, J. Predictive value of phenotypic variables for skin cancer: risk assessment beyond skin typing. Int. J. Dermatol. 45, 1275–1283 (2006).

    Article  Google Scholar 

  7. Bastiaens, M.T. et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am. J. Hum. Genet. 68, 884–894 (2001).

    Article  CAS  Google Scholar 

  8. Han, J., Colditz, G.A. & Hunter, D.J. Risk factors for skin cancers: a nested case-control study within the Nurses' Health Study. Int. J. Epidemiol. 35, 1514–1521 (2006).

    Article  Google Scholar 

  9. Han, J., Kraft, P., Colditz, G.A., Wong, J. & Hunter, D.J. Melanocortin 1 receptor variants and skin cancer risk. Int. J. Cancer 119, 1976–1984 (2006).

    Article  CAS  Google Scholar 

  10. Gudbjartsson, D.F. et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40, 886–891 (2008).

    Article  CAS  Google Scholar 

  11. Sulem, P. et al. Genetic determinants of hair, eye and skin pigmentation in Europeans. Nat. Genet. 39, 1443–1452 (2007).

    Article  CAS  Google Scholar 

  12. Sulem, P. et al. Two newly identified genetic determinants of pigmentation in Europeans. Nat. Genet. 40, 835–837 (2008).

    Article  CAS  Google Scholar 

  13. Markovic, S.N. et al. Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin. Proc. 82, 364–380 (2007).

    Article  Google Scholar 

  14. Gyorgy, B., Toth, E., Tarcsa, E., Falus, A. & Buzas, E.I. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell Biol. 38, 1662–1677 (2006).

    Article  Google Scholar 

  15. Chavanas, S. et al. Peptidylarginine deiminases and deimination in biology and pathology: relevance to skin homeostasis. J. Dermatol. Sci. 44, 63–72 (2006).

    Article  CAS  Google Scholar 

  16. Suzuki, A., Yamada, R. & Yamamoto, K. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann. NY Acad. Sci. 1108, 323–339 (2007).

    Article  CAS  Google Scholar 

  17. Wysocka, J., Allis, C.D. & Coonrod, S. Histone arginine methylation and its dynamic regulation. Front. Biosci. 11, 344–355 (2006).

    Article  CAS  Google Scholar 

  18. Esposito, G. et al. Peptidylarginine deiminase (PAD) 6 is essential for oocyte cytoskeletal sheet formation and female fertility. Mol. Cell. Endocrinol. 273, 25–31 (2007).

    Article  CAS  Google Scholar 

  19. Mollinari, C. et al. The mammalian passenger protein TD-60 is an RCC1 family member with an essential role in prometaphase to metaphase progression. Dev. Cell 5, 295–307 (2003).

    Article  CAS  Google Scholar 

  20. Winkler, S., Mohl, M., Wieland, T. & Lutz, S. GrinchGEF—a novel Rho-specific guanine nucleotide exchange factor. Biochem. Biophys. Res. Commun. 335, 1280–1286 (2005).

    Article  CAS  Google Scholar 

  21. Tao, W., Pennica, D., Xu, L., Kalejta, R.F. & Levine, A.J. Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1. Genes Dev. 15, 1796–1807 (2001).

    Article  CAS  Google Scholar 

  22. Yang, S.H. et al. Pathological responses to oncogenic Hedgehog signaling in skin are dependent on canonical Wnt/β-catenin signaling. Nat. Genet. 40, 1130–1135 (2008).

    Article  CAS  Google Scholar 

  23. Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841–851 (1996).

    Article  CAS  Google Scholar 

  24. Johnson, R.L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668–1671 (1996).

    Article  CAS  Google Scholar 

  25. Emilsson, V. et al. Genetics of gene expression and its effect on disease. Nature 452, 423–428 (2008).

    Article  CAS  Google Scholar 

  26. O'Driscoll, L. et al. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays. Mol. Cancer 5, 74 (2006).

    Article  Google Scholar 

  27. Barrett, J.C. & Cardon, L.R. Evaluating coverage of genome-wide association studies. Nat. Genet. 38, 659–662 (2006).

    Article  CAS  Google Scholar 

  28. Gretarsdottir, S. et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat. Genet. 35, 131–138 (2003).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank G.H. Olafsdottir for assistance in the ascertainment of affected individuals.

Author information

Authors and Affiliations

Authors

Contributions

The study was designed and results were interpreted by S.N.S., D.F.G., P.S., A.K., J.H.O., U.T. and K.S. Statistical analysis was carried out by D.F.G., P.S., G.T., A.H., F.G. and A.K. Subject ascertainment and recruitment was organized and carried out by S.N.S., R.K., B.S., K.R.B., K.T., R.R., D.S., P.R., E.G., K. Koppova, V.M., R.B.-E., V.S., P.J., M.G., F.J.C., P.T., Y.G., K. Kristjansson, G.B., S.G.S., E.N., J.I.M., J.H., J.H.O. and U.T. Biological material collection and handling was supervised by S.N.S., D.S., P.R., E.G., K. Koppova, V.M., R.B.-E., V.S., P.J., M.G., F.J.C., P.T., Y.G., T.R., M.J., J.G., S.T., J.S., K. Kristjansson, S.G.S., E.N., J.I.M., J.H. and U.T. Genotyping was supervised by S.N.S., T.R., M.J., J.G., S.T., M.M. and U.T. Expression analysis was carried out by J.T.B., G.T., A.S., T.T., A.J. and T.B. Bioinformatic analysis was carried out by S.A.G. and G.F.J. Authors S.N.S., D.F.G., P.S., U.T. and K.S. drafted the manuscript. All authors contributed to the final version of the paper. Principal collaborators for the case-control population samples were J.H.O. (Iceland), R.K. (Eastern Europe), J.I.M. and E.N. (Spain), and J.H. (Sweden).

Corresponding authors

Correspondence to Unnur Thorsteinsdottir or Kari Stefansson.

Ethics declarations

Competing interests

Authors whose affiliations are listed as deCODE Genetics are shareholders and/or employees of deCODE Genetics, a biotechnology company. deCODE Genetics intends to incorporate the variants described in this paper into its genetic-testing services.

Supplementary information

Supplementary Text and Figures

Supplementary Tables 1–3 and Supplementary Figures 1 and 2 (PDF 159 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stacey, S., Gudbjartsson, D., Sulem, P. et al. Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits. Nat Genet 40, 1313–1318 (2008). https://doi.org/10.1038/ng.234

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.234

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing